Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines

被引:0
|
作者
Freya JI Fowkes
Julie A Simpson
James G Beeson
机构
[1] Macfarlane Burnet Institute of Medical Research,Centre for Molecular, Environmental, Genetic and Analytic Epidemiology
[2] University of Melbourne,Department of Epidemiology and Preventive Medicine and Department of Infectious Diseases
[3] Monash University,Department of Microbiology
[4] Monash University,Department of Medicine
[5] University of Melbourne,undefined
来源
BMC Medicine | / 11卷
关键词
Malaria; Vaccine; Clinical trials;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] PfSPZ-Based Vaccines: Progress Towards Licensure of a Vaccine for Malaria-Naive and Malaria-Exposed Populations
    Epstein, Judith E.
    Kremsner, Peter Gottfried
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 320 - 320
  • [22] Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development
    Fruscalzo, Arrigo
    Londero, Ambrogio P.
    Bertozzi, Serena
    Lelle, Ralf J.
    MINERVA MEDICA, 2016, 107 (01) : 26 - 38
  • [23] Evaluating antidisease immunity to malaria and implications for vaccine design
    Ademolue, Temitope W.
    Awandare, Gordon A.
    IMMUNOLOGY, 2018, 153 (04) : 423 - 434
  • [24] Second-generation biorefineries: Optimization, opportunities, and implications for Australia
    Bell, Geoffrey
    Industrial Biotechnology, 2017, 13 (02) : 76 - 84
  • [25] A second-generation vaccine protects against the psychoactive effects of cocaine
    Carrera, MRA
    Ashley, JA
    Wirsching, P
    Koob, GF
    Janda, KD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1988 - 1992
  • [26] HHS issues request for proposal for second-generation anthrax vaccine
    Rambhia, Kunal
    Mair, Michael
    BIOSECURITY AND BIOTERRORISM-BIODEFENSE STRATEGY PRACTICE AND SCIENCE, 2008, 6 (02) : 125 - 125
  • [27] EFFICACY OF MURINE MALARIA SPOROZOITE VACCINES - IMPLICATIONS FOR HUMAN VACCINE DEVELOPMENT
    EGAN, JE
    WEBER, JL
    BALLOU, WR
    HOLLINGDALE, MR
    MAJARIAN, WR
    GORDON, DM
    MALOY, WL
    HOFFMAN, SL
    WIRTZ, RA
    SCHNEIDER, I
    WOOLLETT, GR
    YOUNG, JF
    HOCKMEYER, WT
    SCIENCE, 1987, 236 (4800) : 453 - 456
  • [28] FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
    Palatnik-de-Sousa, Clarisa B.
    Barbosa, Andre de Figueiredo
    Oliveira, Sandra Maria
    Nico, Dirlei
    Bernardo, Robson Ronney
    Santos, Wania R.
    Rodrigues, Mauricio M.
    Soares, Irene
    Borja-Cabrera, Gulnara P.
    EXPERT REVIEW OF VACCINES, 2008, 7 (06) : 833 - 851
  • [29] A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children
    Grijalva, Carlos G.
    Pelton, Stephen I.
    CURRENT OPINION IN PEDIATRICS, 2011, 23 (01) : 98 - 104
  • [30] A disanalogy with RCTs and its implications for second-generation causal knowledge
    Lynch, Kate E.
    Brown, Rachael L.
    Strasser, Jeremy
    Yeo, Shang Long
    BEHAVIORAL AND BRAIN SCIENCES, 2023, 46